Part of LifeArc, a self-financing medical research charity, with the ambition to transform the way diseases are identified and treated.
LifeArc Ventures is part of LifeArc, the self-funding medical research charity which grew out of MRC Technology in 2017. LifeArc specialises in early-stage translation-advancing lab-based scientific discoveries, with a commitment to invest £1.3 billion by 2030 to help deliver new diagnostics, drugs, devices, and digital solutions that transform the ways diseases are treated. Building on its royalty interests in the cancer medicine Keytruda™, LifeArc Ventures is a key part of the charity’s financial sustainability strategy to found and fund innovative life sciences companies in the UK, supporting the UK’s globally leading and competitive science base.